Bispecific T-Cell Engagers Targeting Membrane-Bound IgE

The increased incidence of allergies and asthma has sparked interest in IgE, the central player in the allergic response. Interaction with its high-affinity receptor FcεRI leads to sensitization and allergen presentation, extracellular membrane-proximal domain in membrane IgE can act as an antigen r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aleksandra Rodak, Gerhard Stadlmayr, Katharina Stadlbauer, Dominic Lichtscheidl, Madhusudhan Reddy Bobbili, Florian Rüker, Gordana Wozniak-Knopp
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/d5a2f8f936e9455eb7b76ffab63946c1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d5a2f8f936e9455eb7b76ffab63946c1
record_format dspace
spelling oai:doaj.org-article:d5a2f8f936e9455eb7b76ffab63946c12021-11-25T16:49:07ZBispecific T-Cell Engagers Targeting Membrane-Bound IgE10.3390/biomedicines91115682227-9059https://doaj.org/article/d5a2f8f936e9455eb7b76ffab63946c12021-10-01T00:00:00Zhttps://www.mdpi.com/2227-9059/9/11/1568https://doaj.org/toc/2227-9059The increased incidence of allergies and asthma has sparked interest in IgE, the central player in the allergic response. Interaction with its high-affinity receptor FcεRI leads to sensitization and allergen presentation, extracellular membrane-proximal domain in membrane IgE can act as an antigen receptor on B cells, and the interaction with low-affinity IgE receptor CD23 additionally influences its homeostatic range. Therapeutic anti-IgE antibodies act by the inhibition of IgE functions by interfering with its receptor binding or by the obliteration of IgE-B cells, causing a reduction of serum IgE levels. Fusion proteins of antibody fragments that can act as bispecific T-cell engagers have proven very potent in eliciting cytotoxic T-lymphocyte-mediated killing. We have tested five anti-IgE Fc antibodies, recognizing different epitopes on the membrane-expressed IgE, for the ability to elicit specific T-cell activation when expressed as single-chain Fv fragments fused with anti-CD3ε single-chain antibody. All candidates could specifically stain the cell line, expressing the membrane-bound IgE-Fc and bind to CD3-positive Jurkat cells, and the specific activation of engineered CD3-overexpressing Jurkat cells and non-stimulated CD8-positive cells was demonstrated for 8D6- and ligelizumab-based bispecific antibodies. Thus, such anti-IgE antibodies have the potential to be developed into agents that reduce the serum IgE concentration by lowering the numbers of IgE-secreting cells.Aleksandra RodakGerhard StadlmayrKatharina StadlbauerDominic LichtscheidlMadhusudhan Reddy BobbiliFlorian RükerGordana Wozniak-KnoppMDPI AGarticleanti-IgE antibodiesbispecific T-cell engagerscytotoxic T-lymphocyte mediated killingextracellular membrane-proximal domainFcεT-cell activationBiology (General)QH301-705.5ENBiomedicines, Vol 9, Iss 1568, p 1568 (2021)
institution DOAJ
collection DOAJ
language EN
topic anti-IgE antibodies
bispecific T-cell engagers
cytotoxic T-lymphocyte mediated killing
extracellular membrane-proximal domain
Fcε
T-cell activation
Biology (General)
QH301-705.5
spellingShingle anti-IgE antibodies
bispecific T-cell engagers
cytotoxic T-lymphocyte mediated killing
extracellular membrane-proximal domain
Fcε
T-cell activation
Biology (General)
QH301-705.5
Aleksandra Rodak
Gerhard Stadlmayr
Katharina Stadlbauer
Dominic Lichtscheidl
Madhusudhan Reddy Bobbili
Florian Rüker
Gordana Wozniak-Knopp
Bispecific T-Cell Engagers Targeting Membrane-Bound IgE
description The increased incidence of allergies and asthma has sparked interest in IgE, the central player in the allergic response. Interaction with its high-affinity receptor FcεRI leads to sensitization and allergen presentation, extracellular membrane-proximal domain in membrane IgE can act as an antigen receptor on B cells, and the interaction with low-affinity IgE receptor CD23 additionally influences its homeostatic range. Therapeutic anti-IgE antibodies act by the inhibition of IgE functions by interfering with its receptor binding or by the obliteration of IgE-B cells, causing a reduction of serum IgE levels. Fusion proteins of antibody fragments that can act as bispecific T-cell engagers have proven very potent in eliciting cytotoxic T-lymphocyte-mediated killing. We have tested five anti-IgE Fc antibodies, recognizing different epitopes on the membrane-expressed IgE, for the ability to elicit specific T-cell activation when expressed as single-chain Fv fragments fused with anti-CD3ε single-chain antibody. All candidates could specifically stain the cell line, expressing the membrane-bound IgE-Fc and bind to CD3-positive Jurkat cells, and the specific activation of engineered CD3-overexpressing Jurkat cells and non-stimulated CD8-positive cells was demonstrated for 8D6- and ligelizumab-based bispecific antibodies. Thus, such anti-IgE antibodies have the potential to be developed into agents that reduce the serum IgE concentration by lowering the numbers of IgE-secreting cells.
format article
author Aleksandra Rodak
Gerhard Stadlmayr
Katharina Stadlbauer
Dominic Lichtscheidl
Madhusudhan Reddy Bobbili
Florian Rüker
Gordana Wozniak-Knopp
author_facet Aleksandra Rodak
Gerhard Stadlmayr
Katharina Stadlbauer
Dominic Lichtscheidl
Madhusudhan Reddy Bobbili
Florian Rüker
Gordana Wozniak-Knopp
author_sort Aleksandra Rodak
title Bispecific T-Cell Engagers Targeting Membrane-Bound IgE
title_short Bispecific T-Cell Engagers Targeting Membrane-Bound IgE
title_full Bispecific T-Cell Engagers Targeting Membrane-Bound IgE
title_fullStr Bispecific T-Cell Engagers Targeting Membrane-Bound IgE
title_full_unstemmed Bispecific T-Cell Engagers Targeting Membrane-Bound IgE
title_sort bispecific t-cell engagers targeting membrane-bound ige
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/d5a2f8f936e9455eb7b76ffab63946c1
work_keys_str_mv AT aleksandrarodak bispecifictcellengagerstargetingmembraneboundige
AT gerhardstadlmayr bispecifictcellengagerstargetingmembraneboundige
AT katharinastadlbauer bispecifictcellengagerstargetingmembraneboundige
AT dominiclichtscheidl bispecifictcellengagerstargetingmembraneboundige
AT madhusudhanreddybobbili bispecifictcellengagerstargetingmembraneboundige
AT florianruker bispecifictcellengagerstargetingmembraneboundige
AT gordanawozniakknopp bispecifictcellengagerstargetingmembraneboundige
_version_ 1718412985221775360